Eikon Therapeutics develops a proprietary single-molecule tracking platform that utilizes super-resolution microscopy to measure protein dynamics in living cells, enabling detailed analysis of molecular interactions. This technology addresses the challenge of understanding protein behavior, which is critical for identifying new drug targets and advancing therapeutic development for serious diseases.
Funding
$806.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Understanding protein behavior within living cells is crucial for identifying new drug targets and advancing therapeutic development for serious diseases, but traditional methods lack the resolution and scale to effectively analyze molecular interactions and protein dynamics. Existing technologies often fail to capture the transient interactions that define protein activity and function.
Solution
Eikon Therapeutics has developed a proprietary single-molecule tracking (SMT) platform that utilizes super-resolution microscopy to visualize and measure protein dynamics in living cells. This technology enables detailed analysis of molecular interactions by tracking the motion of individual protein molecules, providing insights into their activities and functions. By integrating AI capabilities and advanced automation with SMT, Eikon can inventory molecular interactions with extraordinary scale and precision, facilitating the discovery and development of novel pharmaceuticals. The platform's ability to measure the dynamics of protein populations allows for detailed exploration of the activity of novel pharmaceuticals.
Target Audience
Eikon's primary target audience includes researchers and clinicians focused on drug discovery and development, particularly those working on serious diseases with unmet medical needs in oncology, immunology, and neuroscience.
Features
- Proprietary single-molecule tracking (SMT) platform for visualizing protein motion in living cells.
- Super-resolution microscopy tools for precise measurement of macromolecule dynamics.
- Integration of AI and advanced automation for high-throughput analysis of molecular interactions.
- Ability to measure transient interactions between proteins and other cellular components.
- Capability to explore the activity of novel pharmaceuticals in detail.
- Growing therapeutic pipeline with programs in oncology, immunology, and neuroscience.